Skip to content

Clinical observation of Huanglian Jiedu Decoction in the treatment of Metabolic Syndrome

To study the effect of Huanglian Jiedu Decoction on metabolic syndrome based on the inflammatory mechanism

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043387
Enrollment
Unknown
Registered
2021-02-12
Start date
2021-02-28
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

Sponsors

Changzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.It meets the diagnostic criteria of metabolic syndrome; 2.Aged 18 to 70 years; 3.Signed the Informed Consent; 4.Those who can recheck regularly and cooperate with the treatment.

Exclusion criteria

Exclusion criteria: 1. Those who are suffering from acute diabetic complications within 1 month; 2. Complicated with acute infection; 3. Complicated with severe heart, liver and kidney diseases; 4. Pregnant or lactating women; 5. Patients suffering from acute coronary syndrome or acute stroke; 6. Those who have taken drugs similar to the study drugs or drugs with antagonistic effects in the past 2 months; 7. Those who is currently participating in other drug clinical research projects.

Design outcomes

Primary

MeasureTime frame
fasting blood-glucose;postprandial blood sugar;HbA1C;UA;total cholesterol;triglyceride;low density lipoprotein cholesterin;high density lipoprotein cholesterol;free fatty acid;insulin;TNF-a;IL-6;c reactive protein;WBC;RBC;GRA;LYM;HGB;PLT;ALT;AST;BUN;Cr;

Countries

China

Contacts

Public ContactYaping Wei

Department of Endocrinology, Changzhou Hospital of Traditional Chinese Medicine

weiyapingcz@126.com+86 13641505467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026